US Broker Ratings

Option Care Health (OPCH) Stock Analysis: Navigating a Steady Path in Healthcare with a 16% Return on Equity

Option Care Health, Inc. (NASDAQ: OPCH) stands as a prominent player in the healthcare sector, focusing on medical care facilities and more specifically, home and alternate..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a Challenging Valuation with a 45.48% Potential Downside

For investors eyeing opportunities in the biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) presents a fascinating, albeit challenging, proposition. Known for its pioneering work in mRNA technology,..

Revolution Medicines, Inc. (RVMD) Stock Analysis: High Potential Upside with 36.56% Growth Opportunity

Revolution Medicines, Inc. (NASDAQ: RVMD), a prominent player in the biotechnology sector, is capturing considerable attention from investors with its cutting-edge approach to precision oncology. The..

Elanco Animal Health (ELAN) Stock Analysis: A Strong Buy with 35% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry, presents a compelling..

Gilead Sciences, Inc. (GILD) Stock Analysis: Insights into Growth Potential and Analyst Ratings

Gilead Sciences, Inc. (NASDAQ: GILD) is a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a robust market capitalization of $187.44..

Haleon plc (HLN) Stock Analysis: Evaluating a 28% Potential Upside for Healthcare Investors

Haleon plc (HLN), a prominent player in the healthcare sector, is capturing investor attention with its robust market presence and a potential upside of 28.05%. As..

Legend Biotech Corporation (LEGN) Growth Potential: Analysts Project 148% Upside

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach to developing novel cell therapies targeting..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Growth in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $9.8..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with Strong Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has captured investor attention with its significant market presence and robust financial performance. With..

Bruker Corporation (BRKR) Stock Analysis: Unlocking an 8.2% Potential Upside with Healthcare Innovation

Bruker Corporation (NASDAQ: BRKR), a leading player in the medical devices sector, is making waves with its innovative approaches in scientific instruments and diagnostic solutions. As..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 69.35% Potential Upside in Biotech Innovation

Summit Therapeutics Inc. (NASDAQ: SMMT) is making waves in the biotechnology sector, offering intriguing opportunities for investors with a keen eye on the healthcare industry. As..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Compelling 18.66% Upside Potential for Investors

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization..

Genmab A/S (GMAB) Stock Analysis: Strong Buy Ratings and Nearly 20% Upside Potential

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, is attracting considerable attention from investors, thanks to its encouraging analyst ratings and substantial growth..

Molina Healthcare Inc (MOH) Stock Analysis: Potential Upside Awaits with a 6.19% Promise

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, is drawing attention from individual investors with its intriguing potential upside. With a..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Investor Sentiments Amidst Mixed Ratings

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, stands at the intersection of opportunity and caution for investors. With a market capitalization of..

Madrigal Pharmaceuticals (MDGL) Investor Outlook: Exploring a 44.59% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, has captured the attention of investors with its focus on developing novel therapeutics for..

Stevanato Group S.p.A. (STVN) Stock Analysis: Navigating a 26% Potential Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is making waves with a potential upside of 26.13%. As a key provider of..

Pfizer, Inc. (PFE) Stock Report: Evaluating a Strong Dividend Yield Amidst Market Uncertainty

Pfizer Inc. (PFE), a titan in the healthcare sector, is currently navigating a complex landscape characterized by opportunities and challenges alike. With a market capitalization of..

Humana Inc. (HUM) Stock Analysis: Navigating a Strong Revenue Growth in the Healthcare Sector

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, continues to capture investor interest with its robust performance and strategic positioning within the industry...

Tenet Healthcare Corporation (THC) Stock Analysis: Robust Growth and Strategic Expansion Drive Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. healthcare sector, continues to draw considerable attention from investors due to its strategic expansion and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds